Free Trial

Insmed (INSM) Earnings Date, Estimates & Call Transcripts

$75.06
-0.48 (-0.64%)
(As of 07/18/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 1Estimated
Actual EPS
(May. 9)
-$1.06 Beat By $0.16
Consensus EPS
(May. 9)
-$1.22
Skip Charts & View Estimated and Actual Earnings Data

INSM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

INSM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Insmed Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242($1.19)($1.04)($1.12) 
Q2 20242($1.00)($0.98)($0.99) 
Q3 20242($1.02)($1.00)($1.01) 
Q4 20242($1.05)($0.98)($1.02) 
FY 20248($4.26)($4.00) ($4.13)

INSM Earnings Date and Information

Insmed last announced its earnings results on May 9th, 2024. The biopharmaceutical company reported ($1.06) EPS for the quarter, topping the consensus estimate of ($1.22) by $0.16. The company had revenue of $75.50 million for the quarter, compared to analyst estimates of $77.76 million. Its quarterly revenue was up 15.8% on a year-over-year basis. Insmed has generated ($5.23) earnings per share over the last year (($5.23) diluted earnings per share). Earnings for Insmed are expected to grow in the coming year, from ($4.71) to ($3.79) per share. Insmed has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.

Insmed Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/1/2024
(Estimated)
------- 
5/9/2024Q1 2024($1.22)($1.06)+$0.16($1.06)$77.76 million$75.50 million      
2/22/2024Q4 2023($1.13)($1.28)($0.15)($1.28)$82.15 million$83.70 million      
10/26/2023Q3 2023($1.06)($1.10)($0.04)($1.09)$78.86 million$79.07 million
8/3/2023Q2 2023($1.10)($1.78)($0.68)($1.78)$70.23 million$77.23 million    
5/4/2023Q1 2023($1.08)($1.17)($0.09)($1.17)$63.93 million$65.20 million    
2/23/2023Q4 2022($1.00)($1.20)($0.20)($1.19)$65.78 million$59.30 million
10/27/2022Q3 2022($0.89)($1.09)($0.20)($1.09)$68.02 million$67.73 million
8/4/2022Q2 2022($0.89)($0.80)+$0.09($0.80)$58.92 million$65.20 million      
5/5/2022Q1 2022($0.91)($0.80)+$0.11($0.80)$53.36 million$53.10 million      
2/17/2022Q4 2021($0.89)($0.95)($0.06)($0.95)$50.84 million$56.10 million    
10/28/2021Q3 2021($0.83)($0.96)($0.13)($0.96)$49.23 million$46.80 million    
8/5/2021Q2 2021($0.89)($1.07)($0.18)($0.81)$43.72 million$45.37 million    
5/6/2021Q1 2021($0.91)($0.89)+$0.02($0.89)$41.64 million$40.21 million    
2/25/2021Q4 2020($0.67)($1.00)($0.33)($1.00)$41.44 million$41.42 million    
10/29/2020Q3 2020($0.59)($0.63)($0.04)($0.63)$46.07 million$43.64 million    
8/6/2020Q2 2020($0.58)($0.64)($0.06)($0.64)$34.51 million$42.50 million    
4/30/2020Q1 2020($0.72)($0.74)($0.02)($0.74)$34.81 million$36.90 million    
2/25/2020Q4 2019($0.58)($0.59)($0.01)($0.59)$45.06 million$45.70 million    
10/30/2019Q3 2019($0.67)($0.68)($0.01)($0.68)$35.89 million$38.89 million    
8/1/2019Q2 2019($0.85)($0.81)+$0.04($0.81)$26.30 million$30.00 million    

Insmed Earnings - Frequently Asked Questions

When is Insmed's earnings date?

Insmed has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on INSM's earnings history.

What guidance has Insmed issued on next quarter's earnings?

Insmed updated its FY 2024 earnings guidance on Thursday, May, 9th. The company issued revenue guidance of $340.0 million-$360.0 million, compared to the consensus revenue estimate of $353.5 million.

Did Insmed beat their earnings estimates last quarter?

In the previous quarter, Insmed (NASDAQ:INSM) reported ($1.06) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.22) by $0.16. Learn more on analysts' earnings estimate vs. INSM's actual earnings.

How can I listen to Insmed's earnings conference call?

The conference call for Insmed's latest earnings report can be listened to online. Listen to Conference Call

How can I read Insmed's conference call transcript?

The conference call transcript for Insmed's latest earnings report can be read online. Read Transcript

How can I view Insmed's earnings report?

Insmed's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does Insmed generate each year?

Insmed (NASDAQ:INSM) has a recorded annual revenue of $305.21 million.

How much profit does Insmed generate each year?

Insmed (NASDAQ:INSM) has a recorded net income of -$749.57 million. INSM has generated -$5.23 earnings per share over the last four quarters.

What is Insmed's EPS forecast for next year?

Insmed's earnings are expected to grow from ($4.71) per share to ($3.79) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:INSM) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners